JP6824602B2 - Topical skin agent - Google Patents

Topical skin agent Download PDF

Info

Publication number
JP6824602B2
JP6824602B2 JP2015188242A JP2015188242A JP6824602B2 JP 6824602 B2 JP6824602 B2 JP 6824602B2 JP 2015188242 A JP2015188242 A JP 2015188242A JP 2015188242 A JP2015188242 A JP 2015188242A JP 6824602 B2 JP6824602 B2 JP 6824602B2
Authority
JP
Japan
Prior art keywords
skin
external preparation
mass
present
people
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2015188242A
Other languages
Japanese (ja)
Other versions
JP2017061432A (en
Inventor
弘隆 丹後
弘隆 丹後
優子 新間
優子 新間
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Noevir Co Ltd
Original Assignee
Noevir Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Noevir Co Ltd filed Critical Noevir Co Ltd
Priority to JP2015188242A priority Critical patent/JP6824602B2/en
Publication of JP2017061432A publication Critical patent/JP2017061432A/en
Application granted granted Critical
Publication of JP6824602B2 publication Critical patent/JP6824602B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Cosmetics (AREA)

Description

本発明は、皮膚外用剤に関する。 The present invention relates to an external preparation for skin.

本発明者らは、グリセリン、ジプロピレングリコール、ポリオキシエチレンメチルグルコシド、スクワラン及びテトラ2−エチルヘキサン酸ペンタエリスリットを配合することを特徴とする皮膚プレトリートメント剤で、化粧水の使用の前に皮膚に塗布することを特徴とする皮膚プレトリートメント剤において、後で使用する化粧水の経皮吸収性が高まることを見出した(特許文献1)。 The present inventors are skin pretreatment agents comprising glycerin, dipropylene glycol, polyoxyethylene methyl glucoside, squalane and pentaerythlit tetra2-ethylhexanoate before the use of a lotion. It has been found that in a skin pretreatment agent characterized by being applied to the skin, the transdermal absorbability of a cosmetic solution to be used later is enhanced (Patent Document 1).

特開2011−111722号公報Japanese Unexamined Patent Publication No. 2011-111722

本発明は、特定の保湿成分を配合することにより、次に使用する化粧水等の機能性化粧料の経皮吸収性を高め、肌なじみを良くする皮膚外用剤を提供することを課題とする。 An object of the present invention is to provide an external preparation for skin that enhances the transdermal absorbability of a functional cosmetic such as a cosmetic to be used next and improves the familiarity with the skin by blending a specific moisturizing ingredient. ..

本発明は、(A)ジプロピレングリコール、(B)ポリオキシアルキレンアルキルグルコシド、及び(C)米醗酵液、ポリグルタミン酸又はその塩から選択される一種又は二種以上の成分を含有する皮膚外用剤を提供する。 The present invention is an external preparation for skin containing one or more components selected from (A) dipropylene glycol, (B) polyoxyalkylene alkyl glucoside, and (C) fermented rice liquor, polyglutamic acid or a salt thereof. I will provide a.

本発明の皮膚外用剤は、次に使用する化粧水等の皮膚外用剤の経皮吸収性を高め、肌なじみを良くする効果を発揮する。 The external preparation for skin of the present invention has the effect of enhancing the percutaneous absorbability of the external preparation for skin such as the cosmetic water to be used next, and improving the familiarity with the skin.

以下本発明を実施するための形態を説明する。 Hereinafter, embodiments for carrying out the present invention will be described.

本発明の皮膚外用剤は、(A)ジプロピレングリコール、(B)ポリオキシアルキレンアルキルグルコシド、並びに(C)米醗酵液、ポリグルタミン酸又はその塩から選択される一種又は二種以上を必須成分として含有する。 The external preparation for skin of the present invention contains one or more selected from (A) dipropylene glycol, (B) polyoxyalkylene alkyl glucoside, and (C) fermented rice solution, polyglutamic acid or a salt thereof as essential components. contains.

本発明の皮膚外用剤に配合する(A)ジプロピレングリコールは、通常の皮膚外用剤に配合し得る化合物であれば特に限定されない。
ジプロピレングリコールの配合量は、皮膚外用剤全量に対し、1〜20質量%が好ましく、さらには2〜10質量%配合することが好ましい。1質量%未満若しくは20質量%を超えて配合すると、次に使用する皮膚外用剤の肌なじみを良くする効果が発揮されない場合がある。
The dipropylene glycol (A) blended in the external preparation for skin of the present invention is not particularly limited as long as it is a compound that can be blended in a normal external preparation for skin.
The amount of dipropylene glycol to be blended is preferably 1 to 20% by mass, more preferably 2 to 10% by mass, based on the total amount of the external preparation for skin. If it is blended in an amount of less than 1% by mass or more than 20% by mass, the effect of improving the skin compatibility of the next external preparation for skin may not be exhibited.

本発明の皮膚外用剤に配合する(B)ポリオキシアルキレンアルキルグルコシドとしては、例えば、エチレンオキサイド及びプロピレンオキサイドから選択される1種又は2種のアルキレンオキサイドを、アルキルグルコシドに付加したものを使用することができ、その平均付加モル数としては、1〜30モル程度が好ましい。ポリオキシアルキレンアルキルグルコシドにおけるアルキル基としては、炭素数1〜4のものが好ましく、メチル基、エチル基、プロピル基、イソプロピル基等が好ましい例である。ポリオキシアルキレンアルキルグルコシドの好ましい具体例としては、ポリオキシアルキレンメチルグルコシドが挙げられ、より具体的には、POE(10)メチルグルコシド、POE(20)メチルグルコシド、POP(10)メチルグルコシド及びPOP(20)メチルグルコシド等が挙げられる。これらのポリオキシアルキレンアルキルグルコシドとしては、肌なじみの良さの観点からPOE(20)メチルグルコシドを用いることが最も好ましい。なお、本明細書において、ポリオキシエチレンをPOEと略記し、ポリオキシプロピレンをPOPと略記し、かっこ内の数はその平均付加モル数である。このようなポリオキシアルキレンアルキルグルコシドは、商業的に容易に入手することができる。 As the (B) polyoxyalkylene alkyl glucoside to be blended in the external preparation for skin of the present invention, for example, one or two alkylene oxides selected from ethylene oxide and propylene oxide are added to the alkyl glucoside. The average number of moles added is preferably about 1 to 30 moles. As the alkyl group in the polyoxyalkylene alkyl glucoside, those having 1 to 4 carbon atoms are preferable, and a methyl group, an ethyl group, a propyl group, an isopropyl group and the like are preferable examples. Preferred specific examples of the polyoxyalkylene alkyl glucoside include polyoxyalkylene methyl glucoside, and more specifically, POE (10) methyl glucoside, POE (20) methyl glucoside, POP (10) methyl glucoside and POP ( 20) Examples thereof include methyl glucoside. As these polyoxyalkylene alkyl glucosides, it is most preferable to use POE (20) methyl glucoside from the viewpoint of good skin compatibility. In addition, in this specification, polyoxyethylene is abbreviated as POE, polyoxypropylene is abbreviated as POP, and the number in parentheses is the average number of moles added. Such polyoxyalkylene alkyl glucosides are readily available commercially.

ポリオキシアルキレンアルキルグルコシドは1種又は2種以上を用いることができる。皮膚外用剤中のポリオキシアルキレンアルキルグルコシドの配合量は、皮膚外用剤全量に対し、0.1〜15質量%が好ましく、1〜12質量%がより好ましく、2〜10質量%がさらに好ましい。0.1質量%未満若しくは15質量%を超えて配合すると、次に使用する皮膚外用剤の肌なじみを良くする効果が発揮されない場合がある。 One or more polyoxyalkylene alkyl glucosides can be used. The blending amount of the polyoxyalkylene alkyl glucoside in the external preparation for skin is preferably 0.1 to 15% by mass, more preferably 1 to 12% by mass, still more preferably 2 to 10% by mass, based on the total amount of the external preparation for skin. If it is blended in an amount of less than 0.1% by mass or more than 15% by mass, the effect of improving the skin compatibility of the next external preparation for skin may not be exhibited.

本発明の皮膚外用剤に配合する(C)米醗酵液、ポリグルタミン酸又はその塩から選択される一種又は二種以上は、通常の皮膚外用剤に配合し得る化合物であれば特に限定されない。 One or more selected from (C) rice fermentation broth, polyglutamic acid or a salt thereof to be blended in the external preparation for skin of the present invention is not particularly limited as long as it is a compound that can be blended in a normal external preparation for skin.

米醗酵液は、米もしくは米ぬかを、酵素分解または麹による糖化、酒母或いは酵母による醗酵を行うことにより得られるものを用いることが好ましい。 As the rice fermentation broth, it is preferable to use a rice or rice bran obtained by enzymatically decomposing or saccharifying with koji, or fermenting with sake mother or yeast.

本発明における米醗酵液の配合量は、特に限定されないが、好ましくは、0.01〜10質量%、より好ましくは、0.1〜5%である。0.01質量%未満の配合では充分な保湿効果を得ることができない。また10質量%を超えて配合すると、経時で含有成分であるアミノ酸類が析出したり、着色が認められる場合がある。 The blending amount of the rice fermentation broth in the present invention is not particularly limited, but is preferably 0.01 to 10% by mass, and more preferably 0.1 to 5%. A sufficient moisturizing effect cannot be obtained with a composition of less than 0.01% by mass. Further, if it is blended in an amount of more than 10% by mass, amino acids as contained components may be precipitated or coloring may be observed over time.

本発明で使用するポリグルタミン酸は、遊離の酸または塩の状態で配合する。かかるポリグルタミン酸及び/又はその塩は、グルタミン酸が重合したものであれば特に制限なく用いることができるが、ポリ−γ−グルタミン酸及び/又はその塩であることが好ましい。 The polyglutamic acid used in the present invention is blended in the form of a free acid or salt. Such polyglutamic acid and / or a salt thereof can be used without particular limitation as long as it is a polymer of glutamic acid, but poly-γ-glutamic acid and / or a salt thereof is preferable.

本発明における、ポリグルタミン酸の配合量としては、皮膚外用剤の種類、品質、期待される作用の程度によって若干異なり特に限定しないが、通常、皮膚外用剤全量中、固形分換算して、0.0001質量%以上、好ましくは0.001〜10.0質量%の濃度範囲と定義することが有効である。 The blending amount of polyglutamic acid in the present invention is slightly different depending on the type and quality of the external preparation for skin and the degree of expected action, and is not particularly limited. However, usually, the total amount of the external preparation for skin is converted to 0. It is effective to define the concentration range as 0001% by mass or more, preferably 0.001 to 10.0% by mass.

本発明の皮膚外用剤は、水溶性高分子を配合して粘度を調整することが好ましい。かかる水溶性高分子としては特に限定されないが、アクリル酸系水溶性高分子、及びガム系水溶性高分子から選択される1種又は2種以上を用いることが好ましい。かかるアクリル酸系水溶性高分子、及びガム系水溶性高分子としては、ポリアクリル酸及びその塩、カルボマー、(アクリレーツ/アクリル酸アルキル(C10−30))クロスポリマー、アクリルアミド・アクリルアミド−2−メチルプロパンスルホン酸塩共重合体、アクリル酸ヒドロキシエチル・アクリロイルジメチルタウリン塩共重合体、アクリル酸塩・アクリロイルジメチルタウリン共重合体、アクリル酸アミド・アクリル酸−2−メチルプロパンスルホン酸塩共重合体、アクリロイルジメチルタウリン塩・ビニルピロリドン共重合体などが挙げられ、この中でアクリル酸塩・アクリロイルジメチルタウリン共重合体、アクリル酸アミド・アクリル酸−2−メチルプロパンスルホン酸塩共重合体、及びアクリロイルジメチルタウリン塩・ビニルピロリドン共重合体、アラビアガム、トラガカントガム、グアガム、ジェランガム、シアガム、キャロブガム、カラヤガム、キサンタンガム等が挙げられる。本発明においては、次に使用する皮膚外用剤の肌なじみを改善する目的からアクリル酸系水溶性高分子とガム系水溶性高分子を併用して用いることが好ましく、カルボマー及び(アクリレーツ/アクリル酸アルキル(C10−30))クロスポリマーから選択される1種又は2種と、キサンタンガムを併用することがさらに好ましく、さらには、カルボマーと(アクリレーツ/アクリル酸アルキル(C10−30))クロスポリマーとキサンタンガムの3種を併用して用いることが最も好ましい。 The external preparation for skin of the present invention preferably contains a water-soluble polymer to adjust the viscosity. The water-soluble polymer is not particularly limited, but it is preferable to use one or more selected from the acrylic acid-based water-soluble polymer and the gum-based water-soluble polymer. Examples of the acrylic acid-based water-soluble polymer and the gum-based water-soluble polymer include polyacrylic acid and salts thereof, carbomer, (Acrylate / alkyl acrylate (C10-30)) crosspolymer, and acrylamide / acrylamide-2-methyl. Propanesulfonate copolymer, hydroxyethyl acrylate / acryloyldimethyltaurine salt copolymer, acrylate / acryloyldimethyltaurin copolymer, acrylate / acrylate-2-methylpropanesulfonate copolymer, Acryloyldimethyltaurine salt / vinylpyrrolidone copolymer and the like include acrylate / acryloyldimethyltaurin copolymer, acrylate / acrylate-2-methylpropanesulfonate copolymer, and acryloyldimethyl. Examples thereof include taurine salt / vinylpyrrolidone copolymer, arabic gum, tragacant gum, guagam, gellan gum, shea gum, carob gum, karaya gum, and xanthan gum. In the present invention, it is preferable to use an acrylic acid-based water-soluble polymer and a gum-based water-soluble polymer in combination for the purpose of improving the skin compatibility of the skin external preparation to be used next, and carbomer and (Acrylate / acrylic acid). It is more preferable to use xanthan gum in combination with one or two selected from alkyl (C10-30)) crosspolymers, and further, carbomer and (Acrylate / alkyl acrylate (C10-30)) crosspolymer and xanthan gum. It is most preferable to use these three types in combination.

本発明の皮膚外用剤には上述の必須成分の他に、必要に応じて通常皮膚外用剤に配合される、水性成分、油性成分、保湿剤、色素、界面活性剤、紫外線吸収剤、増粘剤、美容成分、香料、高分子物質、防菌防微剤、アルコール類、粉体、スクラブ剤、生体由来成分等を適宜配合することができる。 In addition to the above-mentioned essential components, the skin external preparation of the present invention usually contains an aqueous component, an oily component, a moisturizer, a pigment, a surfactant, an ultraviolet absorber, and a thickening agent, which are usually added to the skin external preparation as needed. Agents, beauty ingredients, fragrances, polymer substances, antibacterial and microscopic agents, alcohols, powders, scrubbing agents, biological ingredients and the like can be appropriately blended.

本発明の皮膚外用剤は、例えば、ローション剤、乳剤、軟膏の剤型で用いることができる。また、本発明の皮膚外用剤は、製造方法を問わない。 The external preparation for skin of the present invention can be used in, for example, lotions, emulsions, and ointments. In addition, the external preparation for skin of the present invention may be produced regardless of the production method.

本発明の皮膚外用剤は、化粧水の前に使用するプレトリートメント剤として用いるのに好適である。本発明の皮膚外用剤を使用後に化粧水を使用することにより、化粧水のなじみや浸透感がより向上する。 The external preparation for skin of the present invention is suitable for use as a pretreatment agent to be used before a lotion. By using the lotion after using the external preparation for skin of the present invention, the familiarity and penetration of the lotion are further improved.

以下、実施例により本発明を具体的に説明するが、これにより本発明の範囲が限定されるものではない。なお、配合量は特に断りのない限り質量%である。 Hereinafter, the present invention will be specifically described with reference to Examples, but the scope of the present invention is not limited thereto. The blending amount is mass% unless otherwise specified.

Figure 0006824602
Figure 0006824602

<肌なじみ試験>
本発明の皮膚外用剤を塗布した後、化粧水を塗布したときの肌なじみの変化について、10名の専門パネルを用いて官能的に評価した。実施例及び比較例の各試料を塗布後、化粧水A(全量に対して、1,3−ブチレングリコール10質量%、グリセリン5質量%、エタノール7質量%、精製水残部からなる)を塗布した場合に、化粧水Aのみを塗布した場合と比較して化粧水Aの肌なじみが良くなったと答えたパネルの人数により評価し、表1〜3に示した。評価基準は以下の通りとした。
○:良くなったと答えた人数8〜10人
△:良くなったと答えた人数4〜7人
×:良くなったと答えた人数0〜3人
<Skin familiarity test>
After applying the external preparation for skin of the present invention, the change in skin familiarity when the lotion was applied was sensually evaluated using a specialized panel of 10 people. After applying each of the samples of Examples and Comparative Examples, Toner A (consisting of 10% by mass of 1,3-butylene glycol, 5% by mass of glycerin, 7% by mass of ethanol, and the balance of purified water with respect to the total amount) was applied. In this case, the evaluation was made based on the number of panels that answered that the skin familiarity of the lotion A was improved as compared with the case where only the lotion A was applied, and the results are shown in Tables 1 to 3. The evaluation criteria are as follows.
○: Number of people who answered that it improved 8 to 10 people △: Number of people who answered that it improved 4 to 7 people ×: Number of people who answered that it improved 0 to 3 people

<浸透感試験>
本発明の皮膚外用剤を塗布した後、化粧水を塗布したときの浸透感の変化について、10名の専門パネルを用いて官能的に評価した。実施例及び比較例の各試料を塗布後、化粧水A(全量に対して、1,3−ブチレングリコール10質量%、グリセリン5質量%、エタノール7質量%、精製水残部からなる)を塗布した場合に、化粧水Aのみを塗布した場合と比較して化粧水Aの浸透感が良くなったと答えたパネルの人数により評価し、表1〜3に示した。評価基準は以下の通りとした。
○:良くなったと答えた人数8〜10人
△:良くなったと答えた人数4〜7人
×:良くなったと答えた人数0〜3人
<Penetration test>
After applying the external preparation for skin of the present invention, the change in the permeation feeling when the lotion was applied was sensually evaluated using a specialized panel of 10 people. After applying each of the samples of Examples and Comparative Examples, Toner A (consisting of 10% by mass of 1,3-butylene glycol, 5% by mass of glycerin, 7% by mass of ethanol, and the balance of purified water with respect to the total amount) was applied. In this case, the evaluation was made based on the number of panels that answered that the permeation feeling of the lotion A was improved as compared with the case where only the lotion A was applied, and the results are shown in Tables 1 to 3. The evaluation criteria are as follows.
○: Number of people who answered that it improved 8 to 10 people △: Number of people who answered that it improved 4 to 7 people ×: Number of people who answered that it improved 0 to 3 people

Claims (1)

(A)ジプロピレングリコール、
(B)ポリオキシアルキレンアルキルグルコシド、
(C)ポリグルタミン酸又はその塩から選択される一種又は二種以上及び
(D)アクリル酸系水溶性高分子とガム系水溶性高分子(ローカストビーンガムを除く)を併用して含有する皮膚外用剤。
(A) Dipropylene glycol,
(B) Polyoxyalkylene alkyl glucoside,
Topical skin containing (C) one or more selected from polyglutamic acid or a salt thereof, and (D) acrylic acid-based water-soluble polymer and gum-based water-soluble polymer (excluding locust bean gum) in combination. Agent.
JP2015188242A 2015-09-25 2015-09-25 Topical skin agent Active JP6824602B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2015188242A JP6824602B2 (en) 2015-09-25 2015-09-25 Topical skin agent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2015188242A JP6824602B2 (en) 2015-09-25 2015-09-25 Topical skin agent

Publications (2)

Publication Number Publication Date
JP2017061432A JP2017061432A (en) 2017-03-30
JP6824602B2 true JP6824602B2 (en) 2021-02-03

Family

ID=58429917

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015188242A Active JP6824602B2 (en) 2015-09-25 2015-09-25 Topical skin agent

Country Status (1)

Country Link
JP (1) JP6824602B2 (en)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007320889A (en) * 2006-05-31 2007-12-13 Umo Inc Co Ltd Method for preparing face-beautifying medicine
JP2008247752A (en) * 2007-03-29 2008-10-16 Shiseido Co Ltd Composition for external application
JP2011001270A (en) * 2009-06-16 2011-01-06 Shiseido Co Ltd Percutaneous absorption promoter and skin external preparation containing the same
JP5726489B2 (en) * 2010-11-26 2015-06-03 株式会社ノエビア Skin pretreatment agent
JP2013056929A (en) * 2012-11-22 2013-03-28 Rohto Pharmaceutical Co Ltd External preparation for skin
JP2015010070A (en) * 2013-06-28 2015-01-19 富士フイルム株式会社 Melanin decomposition accelerator and melanosome protein decomposition accelerator

Also Published As

Publication number Publication date
JP2017061432A (en) 2017-03-30

Similar Documents

Publication Publication Date Title
US10544384B2 (en) Skin cleansing composition containing rhamnolipid and siloxane
JP4982101B2 (en) Peeling type pack cosmetic
CN110327282A (en) A kind of dandruff control shampoo containing and preparation process improving scalp epidermis microbial flora
JP6071050B2 (en) Skin cosmetics
US20180140540A1 (en) Topical cleansing composition with prebiotic/probiotic additive
TWI284044B (en) Hairdressing cosmetic composition
JP2013506656A (en) O / W type cosmetic composition with improved dosage form stability
CN101878017B (en) Hair care product
JP5892720B2 (en) Skin preparation
US20240139150A1 (en) Methods and compositions suitable for the treatment of acne
JP6824602B2 (en) Topical skin agent
JP2009013117A (en) Hair cosmetic
KR101411803B1 (en) Hair shampoo composition
JP6645746B2 (en) Cosmetics
JP2001247443A (en) Cosmetic for skin
JP4136963B2 (en) Hair cosmetics
JPH10130121A (en) Cosmetic composed of fermentation product of sake lees or distillation by-product of shochu
JP5829578B2 (en) Thickening composition containing acylated amino acids
JP2019077675A (en) Gel-like external preparation for skin and skin cosmetic
WO2024090247A1 (en) Beauty composition, beauty method, and agent for promoting skin permeability of alkoxy salicylic acid or salt thereof
JPH01163113A (en) Hair cosmetic
WO2011118050A1 (en) Emulsion composition
JP4427939B2 (en) Thickener stabilizer
JP6277312B1 (en) Topical skin preparation
CN105168024A (en) Nucleic acid beautifying liquid

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20180822

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20190517

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20190528

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20190725

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20200121

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20200319

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20200630

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20200929

C60 Trial request (containing other claim documents, opposition documents)

Free format text: JAPANESE INTERMEDIATE CODE: C60

Effective date: 20200929

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20201021

C21 Notice of transfer of a case for reconsideration by examiners before appeal proceedings

Free format text: JAPANESE INTERMEDIATE CODE: C21

Effective date: 20201027

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20210107

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20210113

R150 Certificate of patent or registration of utility model

Ref document number: 6824602

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150